| Literature DB >> 33013372 |
Mahmudur Rahman1, Jessica J Browne2, Jacoba Van Crugten2, Md Fahim Hasan3, Lei Liu1, Bronwyn J Barkla1.
Abstract
BACKGROUND: In addition to their use as an edible oil and condiment crop, mustard and rapeseed (Brassica napus L., B. juncea (L.) Czern., B. nigra (L.) W.D.J.Koch, B. rapa L. and Sinapis alba L.) have been commonly used in traditional medicine for relieving pain, coughs and treating infections. The seeds contain high amounts of oil, while the remaining by-product meal after oil extraction, about 40% of seed dry weight, has a low value despite its high protein-content (~85%). The seed storage proteins (SSP) 2S albumin-type napin and 12S globulin-type cruciferin are the two predominant proteins in the seeds and show potential for value adding to the waste stream; however, information on their biological activities is scarce. In this study, purified napin and cruciferin were tested using in silico, molecular docking, and in vitro approaches for their bioactivity as antimicrobial peptides.Entities:
Keywords: 12S globulin; 2S albumin; cruciferin; in silico molecular docking; napin; plant antimicrobial peptide; rapeseed; seed storage protein
Year: 2020 PMID: 33013372 PMCID: PMC7508056 DOI: 10.3389/fphar.2020.01340
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
List of bacteria and controls used in the antimicrobial susceptibility tests.
| Bacteria | Microdilution Antibiotic Positive Controls (ug/ml) | Microdilution Negative Controls |
|---|---|---|
| Gram negative bacteria | Blank: 100 μl CAMHB | |
|
| Ampicillin 128, 64, 32, 16, 8, 4, 2, 1, 0.5, and 0.25 | |
|
| ||
|
| Ampicillin 32, 16, 8, 4, 2, 1, 0.5, 0.25, 0.125, and 0.0625 | |
|
| ||
|
| Gentamicin 32, 16, 8, 4, 2, 1, 0.5, 0.25, 0.125, and 0.0625 | |
| Gram positive bacteria | ||
|
| Ampicillin 32, 16, 8, 4, 2, 1, 0.5, 0.25, 0.125, and 0.0625 | |
|
| Ampicillin 4, 2, 1, 0.5, 0.25, 0.125, 0.0625, 0.031, 0.016, and 0.008 | |
|
| ||
|
|
CAMHB, Cation-Adjusted Mueller-Hinton broth.
SPRINT database search results for napin and cruciferin.
| Protein name | Organism | Reference/Uniprot accession no. |
|---|---|---|
|
| ||
| BNANAPINA |
| Q7DMU4 (Q7DMU4_BRACM) ( |
| Napin-3 |
| P80208 (2SS3_BRANA) |
| Napin-1A |
| P24565 (2SSI_BRANA) |
| Napin-2 |
| P01090 (2SS2_BRANA) |
| Sweet protein mabinlin-4 |
| P80353 (2SS4_CAPMA) |
| Sweet protein mabinlin-2 |
| P30233 (2SS2_CAPMA) |
| Napin-1 |
| P01091 (2SS1_BRANA) |
| Napin-B |
| P27740 (2SSB_BRANA) |
| Allergen Sin a 1 |
| P15322 (ALL1_SINAL) |
| Napin embryo-specific |
| P09893 (2SSE_BRANA) |
|
| ||
| Glutelin type-B 1 |
| P14323 (GLUB1_ORYSJ) |
| Cruciferin CRU1 |
| P33525 (CRU3_BRANA) |
| Glutelin type-A 3 |
| Q09151 (GLUA3_ORYSJ) |
| Glutelin type-B 2 |
| Q02897 (GLUB2_ORYSJ) |
| Glycinin G1 |
| P04776 (GLYG1_SOYBN) |
| Legumin type B |
| P16079 (LEGB6_VICFA) |
| Glutelin type-A 2 |
| P07730 (GLUA2_ORYSJ) |
| Glutelin type-A 1 |
| P07728 (GLUA1_ORYSJ) |
| Legumin K |
| P05693 (LEGK_PEA) |
| Legumin A |
| P09802 (LEGA_GOSHI) |
| Glutelin type-B 4 |
| P14614 (GLUB4_ORYSJ) |
Figure 1(A) Protein motif analysis of antimicrobial signatures (shown in the same color) in napin genes using the PRINTS database. BNANAPINA = Q7DMU4_BRACM = Napin (Q7DMU4) from Brassica campestris; 2SS1_BRANA = Napin-1 (P01091), 2SSI_BRANA = Napin-1A (P24565), 2SSB_BRANA = Napin-B (P27740), 2SS2_BRANA = Napin-2 (P01090), 2SS3_BRANA = Napin-3 (P80208) and 2SSE_BRANA = Napin embryo-specific protein (P09893) are from Brassica napus, ALL1_SINAL = Allergen Sin a 1 (P09893) is from Sinapis alba, and 2SS2_CAPMA = Sweet protein mabinlin-2 (P30233) and 2SS4_CAPMA =Sweet protein mabinlin-4 (P80353) are from Capparis masaikai. The values in the parenthesis are the Uniprot accession numbers ( ). (B) Protein motif analysis of antimicrobial signatures (shown in the same color) in cruciferin genes using the PRINTS database. CRU3_BRANA = Cruciferin CRU1 (P33525) obtained from Brassica napus, GLUA1_ORYSJ = Glutelin type-A 1 (P07728), GLUA2_ORYSJ = Glutelin type-A 2 (P07730), GLUA3_ORYSJ = Glutelin type-A 3 (Q09151), GLUB1_ORYSJ = Glutelin type-B 1 (P14323) are obtained from Oryza sativa subsp. japonica; GLYG1_SOYBN = Glycinin G1 (P04776) from Glycine max, LEGA_GOSHI = Legumin A (P09802) from Gossypium hirsutum, LEGB6_VICFA = Legumin type B (P16079) from Vicia faba, LEGK_PEA = Legumin K (P05693) from Pisum sativum. The values in the parenthesis are the Uniprot accession numbers ( ).
Figure 2High resolution three-dimensional theoretical structural model of (A) napin from rapeseed (Brassica napus) (P09893) based on the structure of the antibacterial sweet protein mabinlin-2 (PDB ID: 2DS2) the template protein and (B) cruciferin based on the structure of antibacterial soybean glycinin (P04776, PDB ID: 1FXZ) from Glycine max the template protein. % identity is between the target protein and the template protein.
Molecular docking scores of ligands (napin and cruciferin) and bacterial receptor proteins (1xbp, 3fra, 3fyv, and 4urm).
| Complex name | Sol no | Global Energy | Softened attractive van der Waals energy | Softened repulsive van der Waals energy | Atomic contact energy | Insideness measure |
|---|---|---|---|---|---|---|
|
| 7 | −0.59 | −1.61 | 0.49 | −0.12 | 2.31 |
| 5 | 9.18 | 0 | 0 | 0 | 13.12 | |
| 6 | 965.84 | −41.1 | 1,273.52 | 3.16 | 5.16 | |
| 9 | 2,121.34 | −24.46 | 2,707.98 | −9.41 | 9.57 | |
| 1 | 5,698.16 | −94.77 | 7,327.33 | −16.89 | 7.82 | |
| 8 | 6,643.37 | −89.32 | 8,488.29 | −11.47 | 7.23 | |
| 3 | 7,793.08 | −87.84 | 9,920.56 | −12.14 | 11.15 | |
| 2 | 8,236.15 | −62.31 | 1,0423.07 | −7.39 | 4.25 | |
| 10 | 95,88.56 | −126.96 | 1,2261.58 | −19.94 | 2.33 | |
| 4 | 12,417.14 | −133.42 | 1,5860.67 | −47.34 | 6.38 | |
|
| 6 | 1.21 | −8.06 | 2.94 | −2.65 | 21.69 |
| 10 | 8.12 | −1.9 | 0.67 | 0.4 | 14 | |
| 7 | 10.63 | −5.51 | 5.89 | 0.78 | 18.47 | |
| 8 | 11.63 | −1.92 | 0.78 | 1.92 | 15.45 | |
| 4 | 12.24 | −0.37 | 0 | 0.47 | 17.22 | |
| 5 | 931.29 | −24.03 | 1,187.66 | 3.16 | 17.37 | |
| 9 | 2,271.55 | −24.4 | 2,845.58 | 13.27 | 14.93 | |
| 1 | 2,348.57 | −37.17 | 3,007.55 | −9.82 | 20 | |
| 3 | 5,195.91 | −48.03 | 6,616.99 | −21.11 | 11.64 | |
| 2 | 6,642.51 | −46.95 | 8,399.35 | −16.86 | 29.19 | |
| 3FRA and napin | 3 | 9.67 | −5.15 | 0.25 | 4.36 | 12.98 |
| 7 | 11.99 | −18.76 | 6.61 | 15.45 | 18.5 | |
| 6 | 13.94 | −29.11 | 26.56 | 9.82 | 15.85 | |
| 2 | 19.23 | −0.75 | 0 | 2.22 | 21.28 | |
| 10 | 356.25 | −26.03 | 468.74 | −3.02 | 3.91 | |
| 9 | 368.1 | −38.18 | 481.56 | 12.76 | 13.88 | |
| 5 | 437.39 | −38.47 | 571.12 | 7.64 | 9.96 | |
| 1 | 447.54 | −29.03 | 593.26 | 0.16 | 5.97 | |
| 8 | 2,125.92 | −58.88 | 2707.8 | 6.13 | 13.04 | |
| 4 | 2,921.04 | −67.41 | 3751.22 | 7.48 | 12.65 | |
| 3FRA and procruciferin | 3 | −18.4 | −33.53 | 9.14 | 6.63 | 18.39 |
| 9 | 7.07 | −33.19 | 18.05 | 5.11 | 18.86 | |
| 8 | 12.74 | −24.81 | 11.45 | 10.97 | 18.18 | |
| 10 | 13.78 | −26.79 | 8.26 | 10.54 | 15.28 | |
| 1 | 14.38 | −28.27 | 14.14 | 17.54 | 20.42 | |
| 7 | 24.06 | −20.77 | 10.71 | 12.52 | 8.85 | |
| 5 | 31.73 | −16.53 | 7.55 | 9.77 | 9.91 | |
| 6 | 35.27 | −44.71 | 14.99 | 22.79 | 26.12 | |
| 4 | 46.04 | −9.72 | 6.78 | 8.46 | 20.11 | |
| 2 | 1,413.49 | −39.03 | 1752.69 | 13.97 | 16.75 | |
| 3fyv and napin | 7 | 10.1 | −2.74 | 0.6 | 3.02 | 19.22 |
| 10 | 28.13 | −23.99 | 12.28 | 12.2 | 15.36 | |
| 8 | 37.82 | −34.61 | 28.57 | 12.7 | 18.12 | |
| 2 | 39.93 | −29.2 | 26.67 | 18.88 | 15.78 | |
| 3 | 45.64 | −18.73 | 17.01 | 13.08 | 16.78 | |
| 9 | 116.89 | −23.22 | 118.17 | 18.87 | 16.1 | |
| 6 | 956.15 | −39.5 | 1,267.32 | 0.69 | 9.89 | |
| 5 | 1,428.16 | −22.18 | 1,797.91 | 14.11 | 11.47 | |
| 1 | 2,298.62 | −51.15 | 2,982.34 | −1.48 | 10.44 | |
| 4 | 4,226.41 | −53.66 | 5,383.38 | 3.23 | 11.43 | |
| 3fyv and procrucifrerin | 3 | −18.35 | −31 | 19.02 | 6.1 | 18.91 |
| 1 | −12.47 | −36.55 | 20.82 | 6.23 | 20.75 | |
| 2 | −7.57 | −20.79 | 17.3 | 6.92 | 16.75 | |
| 8 | −1.86 | −18.25 | 4.4 | 4.97 | 15.95 | |
| 7 | 6.68 | −19.44 | 19.24 | 8.98 | 13.41 | |
| 10 | 12.21 | −23.53 | 23.31 | 11.27 | 17.97 | |
| 5 | 35.64 | −22.45 | 10.36 | 11.19 | 21.6 | |
| 9 | 39.63 | −24.11 | 8.84 | 15.88 | 20 | |
| 6 | 684.27 | −43.27 | 942.18 | 1.59 | 15.88 | |
| 4urm and napin | 7 | −9.16 | −23.05 | 4.03 | 13.03 | 10.4 |
| 6 | −6.66 | −7.2 | 0.69 | 0.73 | 3.46 | |
| 8 | −3.81 | −25.16 | 11.33 | 15.72 | 17.27 | |
| 5 | −3.23 | −14.12 | 3.96 | 5.69 | 8.62 | |
| 2 | 1 | −3.22 | 0 | 1.48 | 11.06 | |
| 10 | 6.79 | −7.07 | 0.22 | 7.88 | 9.47 | |
| 3 | 12.67 | −1.61 | 0 | 1.56 | 16.15 | |
| 9 | 14.97 | −18.85 | 13.87 | 14.34 | 12.75 | |
| 1 | 58.84 | −12.38 | 36.52 | 5.95 | 7.38 | |
| 4 | 317.09 | −46.6 | 421.44 | 16.89 | 10.47 | |
| 4urm and procruciferin | 10 | 2.83 | −2.08 | 0 | 3.29 | 10.25 |
| 6 | 6 | −8.97 | 3.59 | 1.89 | 16.23 | |
| 2 | 6.62 | −8.84 | 6.65 | −0.29 | 19.8 | |
| 4 | 11.86 | −31.63 | 10.19 | 15.62 | 16.63 | |
| 5 | 20.54 | −4.71 | 0.12 | −0.24 | 22.41 | |
| 3 | 34.18 | −7.81 | 0.91 | 5.68 | 16.7 | |
| 9 | 42.57 | −18.89 | 2.96 | 13.63 | 16.95 | |
| 1 | 55.59 | −32.57 | 24.05 | 7.35 | 21.79 | |
| 8 | 85.15 | −27.61 | 93 | 13.49 | 20.4 | |
| 7 | 1,252.18 | −18.68 | 1,600.34 | −0.04 | 6.92 |
Solution numbers are arranged according to the order of the input transformations or models by default settings of online docking server. Global Energy is the binding energy of the solution complex. aVdW, rVdW, softened attractive and repulsive van der Waals energy; ACE, atomic contact energy; inside, insideness measure; aElec, rElec, attractive and repulsive short-range Coulomb electrostatics; laElec, lrElec, attractive and repulsive long-range Coulomb electrostatics; HB, hydrogen and disulfide bonds; CHB, Conventional Hydrogen Bond; piS, PI-PI stacking; catpiS, cation-PI stacking; aliph, aliphatic interactions; Transformation, ligand transformation after refinement. Analysis of the binding interactions of napin and procruciferin with bacterial enzymes showed that the ligand (napin and procruciferin) is surrounded by the amino acids of the bacterial enzymes mentioned in column H. Elec, Electrostatic; AC, Attractive Charge. 1XBP is the 50S ribosomal subunit from Deinococcus radiodurans, 3FRA is Staphylococcus aureus dihydrofolate reductase, 4URM is S. aureus gyrase B, and 3FYV is S. aureus dihydrofolate reductase. Bacterial receptor proteins were selected by efficient global search of relative receptor-ligand interactions (Andrusier et al., 2007; Barakat et al., 2016).
Ligand interactions of the docked complexes with the least global energy of a category.
| The name of the complex | Residue active site | Distance | Bond category | Type of H bond |
|---|---|---|---|---|
| 1xbp and Napin (solution no. 7) | 0:G1:H1 - 0:C2876:N3 | 1.58883 | HB | CHB |
| 0:G1:H22 - 0:C2876:O2 | 1.38916 | HB | CHB | |
| 0:G2:H1 - 0:C2875:N3 | 1.97492 | HB | CHB | |
| 0:G2:H22 - 0:C2875:O2 | 1.43512 | HB | CHB | |
| 0:U3:H3 - 0:A2874:N1 | 1.50205 | HB | CHB | |
| 0:C4:H41 - 0:G2873:O6 | 2.94867 | HB | CHB | |
| 0:A5:H62 - 0:U2871:O4 | 2.9457 | HB | CHB | |
| 0:A5:H62 - 0:U2872:O4 | 2.48541 | HB | CHB | |
| 0:A6:H62 - 0:U2871:O4 | 2.42061 | HB | CHB | |
| 0:G7:H1 - 0:C2870:N3 | 1.64556 | HB | CHB | |
| 1xbp and procruciferin (solution no. 6) | 0:G2044:HO2’ - 0:C2046:OP2 | 2.9279 | HB | CHB |
| 0:G2044:H1 - 0:A2430:N1 | 3.09807 | HB | CHB | |
| 0:G2044:H22 -0:MUL2881:O4 | 1.52911 | HB | CHB | |
| 0:A2430:H62 - 0:G2044:O6 | 2.63632 | HB | CHB | |
| 0:A2482:HO2’ - 0:A2482:O3’ | 1.76876 | HB | CHB | |
| 0:MUL2881:H1 - 0:A2482:N3 | 2.9486 | HB | CHB | |
| 0:G2044:H3’ - 0:G2044:OP2 | 2.75595 | HB | CaHB | |
| 0:G2044:H1’ - 0:A2482:N3 | 2.33872 | HB | CaHB | |
| 0:G2044:H8 - 0:A2482:O4’ | 2.86672 | HB | CaHB | |
| 0:A2045:H8 - 0:A2045:O5’ | 1.93278 | HB | CaHB | |
| 3FRA and napin (solution no. 3) | A:LYS4:NZ - A:GLU8:OE2 | 5.04158 | Elec | AC |
| B:ARG11:NH1 - B:GLU12:OE2 | 5.06307 | Elec | AC | |
| B:GLN6:HE22 - A:GLN1:OE1 | 2.31724 | HB | CHB | |
| A:GLN6:HN - A:PRO2:O | 2.41349 | HB | CHB | |
| A:GLN6:HE21 - A:PRO2:O | 3.01746 | HB | CHB | |
| A:ARG7:HN - A:GLN3:O | 1.64455 | HB | CHB | |
| A:GLU8:HN - A:LYS4:O | 1.55533 | HB | CHB | |
| A:PHE9:HN - A:CYS5:O | 1.92149 | HB | CHB | |
| A:GLN10:HN - A:GLN6:O | 2.24995 | HB | CHB | |
| A:GLN10:HN - A:ARG7:O | 2.43412 | HB | CHB | |
| 3FRA and Procruciferin (solution no. 7) | X:THR1:HT2 – X:GLY87:O | 2.3925 | HB | CHB |
| X:LEU2:HN – X:ASP106:OD2 | 1.62089 | HB | CHB | |
| X:SER3:HN – X:VAL89:O | 1.77077 | HB | CHB | |
| X:SER3:HG – X:ASP107:OD2 | 1.58089 | HB | CHB | |
| X:ILE4:HN – X:ASP107:O | 1.99662 | HB | CHB | |
| X:LEU5:HN – X:ILE91:O | 1.76104 | HB | CHB | |
| X:VAL6:HN – X:TYR109:O | 2.05314 | HB | CHB | |
| X:HIS8:HN – X:THR111:O | 1.85144 | HB | CHB | |
| X:HIS8:HD1 – X:ASP9:0 | 1.70772 | HB | CHB | |
| X:ASP9:HN – X:VAL13:O | 2.01965 | HB | CHB | |
| 3fyv and napin | A:GLN1:HE22 - A:GLN3:OE1 | 2.92555 | HB | CHB |
| A:GLN6:HN - A:PRO2:O | 2.44912 | HB | CHB | |
| A:GLN6:HN - A:GLN3:O | 2.95937 | HB | CHB | |
| A:ARG7:HN - A:GLN3:O | 1.64497 | HB | CHB | |
| A:GLU8:HN - A:LYS4:O | 1.72404 | HB | CHB | |
| A:GLU8:HN - A:GLU8:OE1 | 2.77826 | HB | CHB | |
| A:PHE9:HN - A:CYS5:O | 1.85894 | HB | CHB | |
| A:GLN10:HN - A:GLN6:O | 2.24342 | HB | CHB | |
| A:GLN10:HN - A:ARG7:O | 2.32573 | HB | CHB | |
| A:GLN11:HN - A:ARG7:O | 1.73477 | HB | CHB | |
| 3fyv and procrucifrerin | X:SER136:HG - A:THR86:O | 3.0381 | HB | CHB |
| A:THR86:OG1 - X:GLU138:OE2 | 2.27006 | HB | CHB | |
| B:ARG414:NH1 - X:LEU10:O | 2.72974 | HB | CHB | |
| X:SER136:HB2 - A:THR86:O | 2.89323 | HB | CHB | |
| X:THR1:HT2 - X:GLY87:O | 2.30591 | HB | CHB | |
| X:LEU2:HN - X:ASP106:OD2 | 1.86004 | HB | CHB | |
| X:SER3:HN - X:VAL89:O | 1.79673 | HB | CHB | |
| X:SER3:HG - X:ASP107:OD2 | 1.62549 | HB | CHB | |
| X:ILE4:HN - X:ASP107:O | 2.0698 | HB | CHB | |
| X:LEU5:HN - X:ILE91:O | 1.78562 | HB | CHB | |
| 4urm and napin | C:SER38:OG - D:GLU186:OE2 | 2.74016 | HB | CHB |
| C:SER40:OG - D:GLU186:OE1 | 2.76232 | HB | CHB | |
| C:SER40:OG - D:GLU186:OE2 | 2.90773 | HB | CHB | |
| D:SER40:HG - C:GLU186:OE2 | 3.03646 | HB | CHB | |
| D:ARG42:HH22 - C:GLU186:O | 1.6245 | HB | CHB | |
| C:SER38:OG - D:GLU186:OE2 | 2.74016 | HB | CHB | |
| C:SER40:OG - D:GLU186:OE1 | 2.76232 | HB | CHB | |
| C:SER40:OG - D:GLU186:OE2 | 2.90773 | HB | CHB | |
| D:ARG29:HH11 - D:ALA133:O | 1.80548 | HB | CHB | |
| D:LYS30:HN - D:GLU26:O | 2.13732 | HB | CHB | |
| 4urm and procruciferin | B:ILE183:HN - B:ASP180:O | 2.37223 | HB | CHB |
| B:PHE184:HN - B:ASP180:O | 1.85648 | HB | CHB | |
| B:THR185:HN - B:ILE183:O | 2.37084 | HB | CHB | |
| B:THR187:HG1 - B:VAL189:O | 2.97098 | HB | CHB | |
| B:TYR190:HN - B:ASN75:OD1 | 2.23923 | HB | CHB | |
| B:ASN191:HN - B:HIS45:NE2 | 1.84241 | HB | CHB | |
| B:TYR192:HH - B:ASP225:OD1 | 2.1739 | HB | CHB | |
| B:GLU193:HN - B:ASN191:OD1 | 2.81969 | HB | CHB | |
| B:THR194:HN - B:ASN191:O | 2.67423 | HB | CHB | |
| B:THR194:HN - B:ASN191:OD1 | 2.43501 | HB | CHB |
Figure 3(A) Binding interactions of napin ligand with different proteins using Patchdock. 1XBP is the 50S ribosomal subunit from Deinococcus radiodurans, 3FRA is Staphylococcus aureus dihydrofolate reductase, 4URM is S. aureus gyrase B, and 3FYV is S. aureus dihydrofolate reductase. (B) Binding interactions of procruciferin with different proteins using Patchdock. 1XBP is the 50S ribosomal subunit from Deinococcus radiodurans, 3FRA is Staphylococcus aureus dihydrofolate reductase, 4URM is S. aureus gyrase B, and 3FYV is S. aureus dihydrofolate reductase.
Amino acid composition of napin and cruciferins.
| Napin, 2SSI_BRANA (P24565) | Cruciferin Cru 1 (P33525) | Cruciferin BnC2 (P33524) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of amino acids in napin | Total % of amino acids | Number of amino acids in cruciferin Signal (1–23) | Number of amino acids in alpha chain (24–319) | Number of amino acid in beta chain (320–509) | Total amino acid count | Total % of amino acids | Number of amino acids in cruciferin signal (1–23) | Number of amino acids in alpha chain (24–306) | Number of amino acids in beta chain (307–496) | Total amino acids count | Total % of amino acids | |||
| Ala (A) | 6 | 5.5 | 2 | 11 | 16 | 29 | 6.933 | 2 | 16 | 15 | 33 | 7.43 | ||
| Arg (R) | 6 | 5.5 | 0 | 17 | 12 | 29 | 4 | 1 | 13 | 14 | 28 | 5.43 | ||
| Asn (N) | 4 | 3.6 | 1 | 15 | 16 | 32 | 5.9333 | 0 | 17 | 12 | 29 | 4.1 | ||
| Asp (D) | 1 | 0.9 | 0 | 13 | 5 | 18 | 2.3333 | 0 | 9 | 11 | 20 | 3 | ||
| Cys (C) | 8 | 7.3 | 1 | 4 | 2 | 7 | 2.266 | 0 | 3 | 2 | 5 | 0.73 | ||
| Gln (Q) | 21 | 19.1 | 0 | 63 | 16 | 79 | 9.9 | 0 | 49 | 12 | 61 | 7.86 | ||
| Glu (E) | 6 | 5.5 | 0 | 9 | 12 | 21 | 3.1 | 0 | 11 | 8 | 19 | 2.7 | ||
| Gly (G) | 6 | 5.5 | 2 | 35 | 11 | 48 | 8.766 | 1 | 39 | 13 | 53 | 8.3 | ||
| His (H) | 2 | 1.8 | 1 | 6 | 2 | 9 | 2.466 | 1 | 8 | 1 | 10 | 2.53 | ||
| Ile (I) | 6 | 5.5 | 0 | 15 | 14 | 29 | 4.1667 | 2 | 10 | 12 | 24 | 6.16 | ||
| Leu (L) | 6 | 5.5 | 6 | 18 | 18 | 42 | 13.9 | 5 | 18 | 18 | 41 | 12.53 | ||
| Lys (K) | 5 | 4.5 | 1 | 5 | 5 | 11 | 2.866 | 0 | 8 | 7 | 15 | 2.16 | ||
| Met (M) | 1 | 0.9 | 1 | 5 | 4 | 10 | 2.7 | 1 | 3 | 2 | 6 | 2.16 | ||
| Phe (F) | 6 | 5.5 | 1 | 7 | 5 | 13 | 3.1 | 2 | 13 | 5 | 20 | 5.3 | ||
| Pro (P) | 10 | 9.1 | 1 | 21 | 7 | 29 | 5.0333 | 0 | 17 | 8 | 25 | 3.4 | ||
| Ser (S) | 4 | 3.6 | 0 | 16 | 9 | 25 | 3.3667 | 4 | 17 | 17 | 38 | 10.76 | ||
| Thr (T) | 3 | 2.7 | 1 | 7 | 14 | 22 | 4.7 | 2 | 6 | 11 | 19 | 5.53 | ||
| Trp (W) | 2 | 1.8 | 0 | 4 | 1 | 5 | 0.633 | 0 | 3 | 2 | 5 | 0.73 | ||
| Tyr (Y) | 2 | 1.8 | 0 | 6 | 6 | 12 | 1.733 | 1 | 4 | 6 | 11 | 2.96 | ||
| Val (V) | 5 | 4.5 | 5 | 19 | 15 | 39 | 12 | 1 | 19 | 14 | 34 | 6.13 | ||
| Pyl (O) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Sec (U) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Number of amino acids | 110 | 23 | 296 | 190 | 99.9 | 23 | 283 | 190 | 99.96 | |||||
| Molecular weight | 12,690.53 | 2,408.04 | 32,938.47 | 21,192.11 | 2,541.05 | 3,0825.06 | 2,0960.66 | |||||||
| Theoretical pI | 8.71 | 8 | 7.17 | 6.94 | 8.52 | 7.95 | 8.6 | |||||||
| Total number of negatively charged sesidues (Asp + Glu) | 7 | 0 | 22 | 17 | 0 | 20 | 19 | |||||||
| Total number of Positively charged sesidues (Arg + Lys) | 77 | 1 | 22 | 17 | 1 | 21 | 21 | |||||||
| Atomic composition | ||||||||||||||
| C | 557 | 113 | 1,415 | 929 | 119 | 1,337 | 917 | |||||||
| H | 864 | 191 | 2,222 | 1,500 | 190 | 2,073 | 1,475 | |||||||
| N | 164 | 27 | 446 | 268 | 28 | 415 | 267 | |||||||
| O | 159 | 26 | 448 | 286 | 31 | 417 | 287 | |||||||
| S | 9 | 2 | 9 | 6 | 1 | 6 | 4 | |||||||
| Formula | C557H864N164O159S9 | C113H191N27O26S2 | C1415H2222N268O448S9 | C929H1500N268O286S6 | C119H190N28O31S1 | C1337H2073N415O417S6 | C917H1475N267O287S6 | |||||||
| Total Number of atoms | 1,753 | 359 | 4,540 | 2,989 | 369 | 4,248 | 2,950 | |||||||
| Aliphatic index | 61.18 | 173.48 | 65.81 | 97 | 140 | 63.71 | 90.84 | |||||||
| GRAVY | −0.661 | 1.778 | −0.903 | −0.226 | 1.274 | −0.753 | −0.326 | |||||||
GRAVY, Grand average of hydrophobicity.
Figure 4Plate images of disc diffusion antimicrobial susceptibility testing as per EUCAST guidelines for napin and cruciferin proteins against four Gram positive and five Gram negative bacteria, labeled electronically to reflect the actual concentrations tested. The agar plates used for the testing of the purified napin protein are labeled with the doses corresponding to 40 µg down to 1.25 µg, while plates used to test the purified cruciferin protein are labeled with the doses corresponding to 30.8 µg down to 0.9625 µg. The plates were labeled prior to the solubilization of the proteins (and subsequently, lower working concentrations were prepared for cruciferin 1, due to additional solvents added for solubilization). +v indicates that positive control antibiotics showing the expected zones of inhibition ≥14 mm (1.25 µg/23.75µg of Trimethoprim/Sulfamethoxazole) and ≥26 mm (5-µg Ciprofloxacin). B at the center indicates the blank negative control.
Figure 5Graph showing the antimicrobial activity of napin and cruciferin against four Gram positive and five Gram negative bacteria, measured in microdilution antimicrobial susceptibility tests according to CLSI guidelines. The colors representing each bacterium are given at the top of the graph.
Figure 6Multiple sequence alignment of Brassica napus napin proteins available in publicly open databases ( ) and napin proteins identified in Brassica rapa R-o-18 aligned using the program Clustal Omega [Rahman et al., 2016; Rahman et al., 2017; Rahman et al., 2018a; Rahman et al., 2020; Rahman, 2020 (in preparation)], indicates significant identity of the two proteins. Cov, sequence coverage; pid, percent identity.
Molecular docking scores of ligands (napin and cruciferin) and bacterial receptor proteins (1xbp, 3fra, 3fyv, and 4urm).
| Complex name | Sol no | aElec | rElec | laElec | lrElec | HB | piS | catpiS | aliph | Transformation |
|---|---|---|---|---|---|---|---|---|---|---|
|
| 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −2.182 0.785 −0.167 153.825 85.611 72.471 |
| 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −2.546 0.068 0.002 107.452 28.385 110.538 | |
| 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.055 0.849 −1.166 90.032 169.446 145.327 | |
| 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.831 0.483 −1.078 114.903 66.700 61.513 | |
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −2.716 −0.099 −0.070 103.328 74.379 76.142 | |
| 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −0.435 −0.617 1.439 100.459 74.442 79.054 | |
| 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −0.432 0.132 −3.035 101.192 71.071 75.851 | |
| 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −0.446 0.219 −2.705 102.389 70.811 74.034 | |
| 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −1.959 −0.076 −2.320 100.384 71.509 77.724 | |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.622 −0.218 −1.907 109.921 69.589 72.565 | |
|
| 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −1.479 −0.555 −0.584 157.666 116.809 83.178 |
| 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.050 −0.527 −0.712 157.651 121.770 178.506 | |
| 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.861 −0.884 −2.532 132.500 −12.579 49.529 | |
| 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −2.937 0.836 −2.558 120.442 27.038 99.815 | |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.305 0.080 2.319 93.522 27.314 125.913 | |
| 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −2.781 −0.979 −1.829 124.149 −5.545 92.508 | |
| 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −0.348 −0.341 1.407 135.052 73.380 18.199 | |
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −2.786 −0.160 −2.122 86.345 −2.855 45.882 | |
| 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.014 −0.912 2.859 36.535 187.629 −33.873 | |
| 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −2.169 −0.881 2.534 136.756 46.109 89.104 | |
|
| 3 | 0 | 0 | 0 | 3.65 | −1.16 | 0 | 0 | 0 | −0.374 0.333 −2.558 48.513 22.971 58.415 |
| 7 | 0 | 2.53 | 0 | 5.59 | −4.27 | 0 | −3 | 0 | 2.498 0.263 0.565 31.811 −9.349 22.582 | |
| 6 | −39.57 | 49.91 | −14.84 | 25.75 | −3.61 | −5 | −1.5 | 0 | 0.777 −0.920 0.031 31.240 −6.76720.236 | |
| 2 | −18 | 13.15 | −5.6 | 4.24 | 0 | 0 | 0 | 0 | −1.844 −0.378 2.308 33.992 13.213 72.834 | |
| 10 | 0 | 44.64 | 0 | 28.65 | −3.13 | −3 | 0 | 0 | −1.866 0.052 −1.199 54.995 6.205 39.585 | |
| 9 | −31.84 | 52.4 | −2.64 | 20 | −5.53 | −1.5 | 0 | 0 | 2.809 −0.276 −1.675 32.913 −6.274 20.409 | |
| 5 | −3.67 | 92.55 | −8.86 | 14.77 | −5.3 | −3.5 | 0 | 0 | −1.765 −0.023 −1.244 52.431 5.865 40.971 | |
| 1 | −4.3 | 12.91 | −3.53 | 27.28 | −4.66 | −3 | 0 | 0 | −1.910 −0.035 −1.076 55.277 9.872 38.750 | |
| 8 | 0 | 168.99 | −13.9 | 16.5 | −8.96 | −6 | −1.5 | 0 | 1.154 −0.855 0.068 30.797 −3.343 19.271 | |
| 4 | −18.94 | 63.43 | −5.72 | 13.39 | −7.83 | −8.5 | −0.5 | 0 | −2.319 −0.115 −2.030 42.600 −6.846 29.913 | |
|
| 7 | −63.76 | 76.16 | −26.94 | 7.65 | −2.6 | −0.5 | −4.5 | 0 | −2.395 −0.295 3.104 −40.270 5.564 75.524 |
| 5 | −47.32 | 155.69 | −20.65 | 12.73 | −7.49 | −1.5 | 0 | 0 | −2.400 1.033 1.077 61.649 63.589 28.921 | |
| 6 | −33.43 | 83.8 | −15.12 | 5.66 | −2.01 | −0.5 | −1.5 | 0 | −1.829 −1.362 −0.374 −21.860 23.311 19.302 | |
| 9 | −9.05 | 70.71 | −19.39 | 24.64 | −4.39 | −3.5 | −2 | 0 | 2.402 −0.332 −1.654 −27.722 −6.950 50.787 | |
| 1 | −77.85 | 44.59 | −31.15 | 25.54 | −3.36 | −3.5 | 0 | 0 | −1.451 1.285 −1.855 53.382 −39.770 50.677 | |
| 8 | −9.3 | 6.63 | −11.71 | 35.54 | −1.28 | −2 | 0 | 0 | −0.997 −0.228 0.402 67.781 63.930 47.546 | |
| 3 | −35.06 | 88.26 | −21.91 | 27.64 | −1.53 | −0.5 | 0 | 0 | 0.037 −0.982 2.915 −18.447 −36.805 −29.202 | |
| 2 | −97.95 | 166.22 | −19.3 | 37.74 | −2.73 | −1.5 | 0 | 0 | −1.708 −0.533 −1.055 −17.817 −34.684 8.139 | |
| 10 | 0 | 97.58 | −9.94 | 14.63 | −2.21 | 0 | −0.5 | 0 | −1.396 −0.553 0.583 50.656 74.284 19.120 | |
| 4 | −7.53 | 126.93 | −26.95 | 30.3 | −4.65 | −4.65 | −3 | 0 | 2.312 −0.378 −1.677 −26.461 −9.600 53.378 | |
|
| 7 | −18.13 | 0 | −2.56 | 0 | −0.63 | 0 | 0 | 0 | 1.195018 0.111900 −0.404503 36.603848 13.070419 67.113762 |
| 10 | −4.79 | 57.17 | −8.34 | 26.33 | −0.92 | −3 | −1.5 | 0 | 1.419516 1.422478 −0.341556 48.927547 4.558572 42.616772 | |
| 8 | 0 | 113.12 | −2.71 | 24.28 | −3.99 | −1.5 | −0.5 | 0 | 0.897423 −0.512778 0.087532 38.153831 −4.305618 22.148920 | |
| 2 | −12.15 | 64.62 | −5.29 | 25.39 | −4.08 | −2.5 | 0 | 0 | 0.571090 −0.669658 −0.104022 34.059589 −7.079601 22.993988 | |
| 3 | 0 | 33.55 | −2.32 | 31.86 | −1.32 | 0 | 0 | 0 | 0.327455 1.276970 2.856120 54.459126 8.206043 44.482044 | |
| 9 | 0 | 38.48 | −2.61 | 14.07 | −1.43 | 0 | −0.5 | 0 | 2.365478 0.011664 1.090053 35.474125 −9.137678 22.458466 | |
| 6 | −4.16 | 0 | −7.4 | 3.81 | −4.35 | −3 | 0 | 0 | 0.186018 −0.592759 2.217820 21.126738 36.698421 53.015606 | |
| 5 | −73.96 | 26.78 | −27.29 | −27.29 | −4.61 | −1.5 | −1.5 | 0 | −1.635767 −0.367702 1.973211 6.267393 32.485970 42.305016 | |
| 1 | 0 | 0 | −2.41 | 0 | −10.39 | −3 | 0 | 0 | 0.183982 −0.287892 1.906260 25.036688 33.092117 58.026882 | |
| 4 | −5.03 | 0 | −8.11 | 0 | −8.82 | −1 | −0.5 | 0 | −0.185922 0.394067 −1.593941 26.694721 12.248711 70.375458 | |
|
| 3 | −98.07 | 83.04 | −17.98 | 9.03 | −8.49 | −0.5 | −3.5 | 0 | 0.882312 0.270622 0.452004 34.376209 16.761656 105.629204 |
| 1 | −61.41 | 84.22 | −22.21 | 5.66 | −2.95 | −1.5 | −3.5 | 0 | −2.408909 −0.310804 3.137617 −40.343742 3.093425 74.197830 | |
| 2 | −140.35 | 79.66 | −6.04 | 7.93 | −3.92 | 0 | −1.5 | 0 | −0.871412 0.289663 −1.703906 −3.532524 −71.564064 81.714600 | |
| 8 | −71.86 | 42.05 | −18.43 | 25.3 | −1.69 | −1.5 | −1.5 | −1.5 | −2.924418 −1.277309 −0.012886 −4.014475 −30.156733 16.353909 | |
| 7 | −19.67 | 5.26 | −2.47 | 4.59 | −2.47 | −0.5 | 0 | 0 | −1.000771 −0.166307 2.180230 29.872753 95.077187 34.847866 | |
| 10 | −4.48 | 2.47 | −16.22 | 1.67 | −0.83 | −1.5 | 0 | 0 | 1.584941 1.442978 1.329863 17.483091 −43.860760 60.712036 | |
| 5 | −44.84 | 84.56 | −22.3 | 40.69 | −4.93 | −2.5 | 0 | 0 | −2.497311 1.305315 −0.634158 63.377178 −31.635798 44.732738 | |
| 9 | −31.71 | 130.52 | −30.34 | 19.31 | −2.67 | −0.5 | −1.5 | 0 | −2.693943 0.193235 0.101170 114.073677 8.710386 87.306931 | |
| 6 | −68.99 | 58.52 | −39 | 11.46 | −12.24 | −5.5 | 0 | −1.5 | 0.541106 0.042602 −0.569371 98.065758 −28.758331 7.812671 | |
| 3 | 0 | 90.92 | −3.16 | 11.64 | −7.58 | −4.5 | −0.5 | −0.5 | −0.486131 1.271754 −2.446670 46.617748 −29.963055 47.164417 | |
|
| 7 | −98.45 | 64.66 | −54.86 | 8.7 | −2.99 | 0 | 0 | −0.5 | 1.868066 −0.092131 1.525814 3.637999 −3.130833 89.582695 |
| 6 | −21.61 | 5.28 | −8.68 | 9.4 | −1.67 | 0 | −1.5 | 0 | −1.460179 0.502492 1.252873 −0.179193 −0.899414 90.955017 | |
| 8 | −37.47 | 2.22 | −18.01 | 6.93 | −7.41 | −0.5 | −0.5 | 0 | −2.274868 −0.086826 1.442803 −1.433655 −8.620634 21.917574 | |
| 5 | 0 | 0 | −11.27 | 5.51 | −3.48 | 0 | 0 | 0 | 2.159986 0.164253 −1.314865 0.505913 −3.224665 87.916992 | |
| 2 | −17.01 | 0 | −2.35 | 0 | −0.59 | 0 | 0 | 0 | −1.886352 −0.360272 2.477731 −30.973713 −4.360527 86.722488 | |
| 10 | −3.7 | 0 | −23.82 | 0 | 0 | 0 | 0 | −0.5 | −2.866194 0.273189 −1.994032 −2.115814 0.507240 85.711090 | |
| 3 | 0 | 0 | 0 | 3.38 | −0.87 | 0 | 0 | 0 | −0.317704 −0.848188 −0.778242 1.825974 0.354532 101.007179 | |
| 9 | −77.7 | 42.28 | −23.21 | 15.08 | −2.23 | 0 | 0 | 0 | 1.982411 0.129197 −0.731296 3.800283 3.508109 88.668083 | |
| 1 | −26.53 | 96.95 | −11.3 | 33.03 | −0.43 | 0 | −1.5 | −1 | −2.776647 −0.022754 2.788598 −6.041031 −2.748431 83.736801 | |
| 4 | −13.84 | 65.53 | −22.31 | 18.81 | −3.28 | −3 | −2 | 0 | 2.470320 0.397040 −2.668524 6.743612 −16.430897 23.362900 | |
|
| 10 | −36.17 | 5.34 | −14.5 | 0 | 0 | 0 | 0 | 0 | 1.135997 −0.824196 −0.303326 0.146988 1.550484 90.916000 |
| 6 | −22.1 | 14.31 | −4.85 | 8.27 | −1.27 | 0 | −0.5 | 0 | 0.572244 1.138489 1.520022 54.118980 70.514359 110.521210 | |
| 2 | 0 | 0 | 0 | 6.37 | −1.25 | −0.5 | 0 | −0.5 | 0.100003 1.048633 −0.000666 96.403412 −40.060814 111.336456 | |
| 4 | −65.72 | 98.02 | −36.28 | 28.24 | −2.67 | 0 | −1.5 | −3 | −2.418812 0.821444 −1.755734 −42.335209 −13.986760 148.038712 | |
| 5 | 0 | 29.32 | −3.1 | 8.75 | 0 | 0 | 0 | 0 | 2.891166 −0.650604 −1.210649 −9.728887 −14.524008 98.395508 | |
| 3 | 0 | 32.64 | 0 | 25.43 | 0 | 0 | 0 | 0 | −1.590922 0.173499 −0.392852 10.746419 5.179658 91.331253 | |
| 9 | −12.58 | 77.45 | −24.05 | 37.72 | −3.99 | 0 | 0 | 0 | −2.217826 −1.256601 −2.375825 −26.934299 46.748051 64.341164 | |
| 1 | −72.36 | 167.22 | −25.94 | 63.32 | −3.48 | 0 | 0 | −0.5 | −2.266007 0.966959 −2.883063 25.514585 −12.810349 162.878510 | |
| 8 | 0 | 52.53 | −2.58 | 11.68 | −2.33 | 0 | 0 | 0 | 1.868728 0.001705 −0.450134 102.784889 19.933956 61.477333 | |
| 7 | 0 | 0 | 0 | 0 | −4.04 | 0 | 0 | 0 | 0.937499 0.348988 1.225773 9.959099 −7.660954 132.986313 |
aElec, rElec, attractive and repulsive short-range Coulomb electrostatics; laElec, lrElec, attractive and repulsive long-range Coulomb electrostatics; HB, hydrogen and disulfide bonds; piS, PI-PI stacking; catpiS, cation-PI stacking; aliph, aliphatic interactions; Transformation, ligand transformation after refinement; Sol no, Solution number. 1XBP is the 50S ribosomal subunit from Deinococcus radiodurans, 3FRA is Staphylococcus aureus dihydrofolate reductase, 4URM is S. aureus gyrase B, and 3FYV is S. aureus dihydrofolate reductase. All the other sequences were retrieved from the GenBank database and are as follows (source species and sequence accession numbers are shown in parenthesis): Mabinlin-II (Capparis masaikai; P30233), Sesa1 (Arabidopsis thaliana; P15457), Napin-2 (Brassica napus; P01090), Sin a 1 (Sinapis alba; P15322), Napin-1A (B. napus; P24565), Ric c 3 (Ricinus communis; P01089), Ber e 1 (Bertholletia excelsa; P04403), Ric c 1 (R. communis; P01089), and Gm2S-1 (Glycine max; P19594). Bacterial receptor proteins were selected by efficient global search of relative receptor-ligand interactions (Andrusier et al., 2007; Barakat et al., 2016).